id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-V-1290-0003,FDA,FDA-2021-V-1290,Variance Approval Letter from FDA CDRH to Sergio Rangel,Other,Approval for Variance (VRA),2021-12-28T05:00:00Z,2021,12,2021-12-28T05:00:00Z,,2021-12-28T17:35:41Z,,0,0,0900006484eff191
FDA-2021-V-1290-0002,FDA,FDA-2021-V-1290,Acknowledgment Letter from FDA DMS to Sergio Rangel,Other,Acknowledgement Letter/Receipt,2021-12-09T05:00:00Z,2021,12,2021-12-09T05:00:00Z,,2021-12-09T14:34:08Z,,0,0,0900006484ea3f13
FDA-2021-V-1290-0001,FDA,FDA-2021-V-1290,Variance Application from Sergio Rangel,Other,Application for Variance (VAR),2021-12-09T05:00:00Z,2021,12,2021-12-09T05:00:00Z,,2021-12-09T13:23:22Z,,0,0,0900006484ea3f11